Table 3 Differences in the differential blood counts between the five groups

From: Safety and efficacy of a novel glycoengineered recombinant vaccine candidate against Haemonchus contortus in sheep

Group ID

Mean [95%CI]

Overall p value

Lymphocytes /µl

 NEGa*

4144.92 [3892.84; 4396.99]

< 0.01

 POSb**

3890.61 [3638.54; 4142.68]

 BVAX

4391.28 [4139.21; 4643.35]

 GEAa*,b**,c*

4679.40 [4427.33; 4931.48]

 NEAc*

4004.36 [3752.28; 4256.43]

Monocytes /µl

 NEG

167.00 [139.39; 194.61]

0.08

 POS

143.44 [115.83; 171.05]

 BVAX

165.81 [138.21; 193.42]

 GEA

148.53 [120.92; 176.14]

 NEA

116.57 [88.96; 144.18]

Eosinophil Granulocytes /µl

 NEGa**

97.38 [28.44; 166.33]

< 0.01

 POSb**

138.45 [69.50; 207.40]

 BVAXa**,b**,c**,d**

507.17 [438.22; 576.11]

 GEAc**

188.82 [119.87; 257.76]

 NEAd**

143.78 [74.83; 212.72]

Basophil Granulocytes /µl

 NEGa**

36.33 [31.22; 41.43]

< 0.01

 POSb**

36.96 [31.85; 42.06]

 BVAXa**,b**,c**

52.75 [47.65; 57.86]

 GEA

42.82 [37.71; 47.93]

 NEAc**

33.78 [28.67; 38.88]

Segmented Granulocytes /µl

 NEGa**,b**,c**,d**

1874.23 [1755.93; 1992.52]

< 0.01

 POSa**

1292.75 [1174.46; 1411.05]

 BVAXb**

1421.45 [1303.16; 1539.75]

 GEAc**,e*

1514.37 [1396.07; 1632.66]

 NEAd**,e*

1233.35 [1115.05; 1351.64]

  1. Mean values and 95% confidence intervals are shown, the significance level was set at p ≤ 0.05. All superscript letters highlighted by * indicate p values ≤ 0.05. Superscript letters with ** indicate p values < 0.01. The p values in the right column indicate differences between the groups overall.
Back to article page